ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Abilify Maintena 400 mg, Depot-Injektionssuspension in einer Fertigspritze - Fertigspritze(n)
65774001 Lundbeck (Schweiz) AG
Abilify Maintena 400 mg, Depot-Injektionssuspension in einer Fertigspritze15.03.2016
  15.03.2016
Aripiprazole (N05AX12) 
WHO-DDD 
01.05.Fertigspritze(n)
01.05. 
B  
Yes 
IP 
342.02No
    
10 %409.45
7680657740011Synthetika
6630966 
Composition
Praeparatio cryodesiccata: aripiprazolum 400 mg ut aripiprazolum monohydricum, carmellosum natricum, mannitolum, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, ad pulverem. Solvens: aqua ad iniectabile. Solutio reconstituta: aripiprazolum 400 mg ut aripiprazolum monohydricum, carmellosum natricum, mannitolum, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium max. 2.2 mg.
Packungsbestandteile
Praeparatio cryodesiccata:
 
Depot-Injektionssuspension in einer Fertigspritze 
  
 
Active AgentDose
Aripiprazole400 mg
BAG: Active AgentDose
Aripiprazole400 mg
 
Inactive agents
Carmellose Sodium
Mannitol
Sodium Dihydrogenophosphate Monohydrate
Sodium Hydroxide
 
Source
Data was imported : 06.07.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home